Advertisement

ECI Biotech Inc. has entered into an agreement with Systagenix Wound Management Inc., a subsidiary of Johnson & Johnson, designed to spur the development of diagnostic sensors to help diagnose and treat chronic wounds.

ECI Biotech, the Worcester-based developer of the sensors, said it would open a new manufacturing facility, also in Worcester, and create 12 new jobs as a result of the deal, over the next two years, said Jodie Luksha, director of marketing for the company. The goal is to make it easier to detect the underlying causes of chronic wounds, faster than traditional lab cultures, which can take two to three days.

SOURCE

Advertisement
Advertisement